Tested applications
WB
Uniprot #
P01135
Category
Antibody
Recognised antigen
TGF alpha
French translation
anticorps
Conjugation
Unconjugated
Purity
Antigen affinity
Clone
Polyclonal antibody
Recommended dilutions
Western blot: 0.5-1ug/ml
Form
Antigen affinity purified
Clonality
Polyclonal (rabbit origin)
Host animal
Rabbit (Oryctolagus cuniculus)
Concentration
0.5mg/ml if reconstituted with 0.2ml sterile DI water
Additional description
The Anti-TGF alpha is a α- or alpha protein sometimes glycoprotein present in blood.
Intented use
This TGF alpha antibodyis to be used only for research purposes and not for diagnostics..
Immunogen
Amino acids 73-89 (CHSGYVGARCEHADLLA-human) were used as the immunogen for this TGF alpha antibody.
Properties
If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
Species reactivity
Human (Homo sapiens) ; Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur.
Notes
The stated application concentrations are suggested starting amounts. Titration of the TGF alpha antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Storage
After reconstitution, the TGF alpha antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20 deg. Celcius or lower. Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity. Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized. Avoid repeated freezing and thawing.
Description
Transforming growth factor a is upregulated in some human cancers. It is produced in macrophages, brain cells, and keratinocytes, and induces epithelial development. It is closely related to EGF, and can also bind to the EGF receptor with similar effects . TGF alpha stimulates neural cell proliferation in the adult injured brain. TG Falpha was cited in the 2001 NIH Stem Cell report to the U.S. Congress as promising evidence for the ability of adult stem cells to restore function in neurodegenerative disorders.